Grey Wolf Health Corp. (TSXV:WOLF)
Canada · Delayed Price · Currency is CAD 1.590
-0.110 (-6.47%)
Jul 27, 2026, 11:29 AM EST
Grey Wolf Health Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 55 | 45 | 38 | 23 | 24 | - | |
Market Cap Growth | 52.76% | 18.92% | 65.28% | -5.13% | - | - |
Enterprise Value | 71.03 | 62.94 | 59.14 | 25.1 | 28.37 | 0 |
Last Close Price | 1.59 | 1.32 | 1.11 | 0.74 | 0.78 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 30.68 | 26.40 | 55.50 | 37.00 | 5.13 | - |
PS Ratio | 1.50 | 1.26 | 1.41 | 0.90 | 1.07 | - |
PB Ratio | 1.77 | 1.48 | 1.32 | 0.92 | 1.00 | - |
P/TBV Ratio | - | - | - | 13.71 | - | - |
P/FCF Ratio | 14.21 | 13.63 | 31.30 | 10.68 | - | - |
P/OCF Ratio | 12.74 | 11.78 | 21.73 | 9.44 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.94 | 1.76 | 2.20 | 0.99 | 1.25 | - |
EV/EBITDA Ratio | 10.24 | 9.31 | 17.23 | 8.34 | 23.63 | - |
EV/EBIT Ratio | 16.84 | 15.52 | 31.04 | 16.14 | - | - |
EV/FCF Ratio | 18.41 | 19.00 | 48.77 | 11.68 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.73 | 0.76 | 0.88 | 0.35 | 0.40 | 5.11 |
Debt / EBITDA Ratio | 3.60 | 3.77 | 8.04 | 3.30 | 9.19 | 18.38 |
Debt / FCF Ratio | 6.47 | 7.69 | 22.76 | 4.62 | - | 10.32 |
Net Debt / Equity Ratio | 0.52 | 0.58 | 0.74 | 0.09 | 0.17 | 4.31 |
Net Debt / EBITDA Ratio | 2.33 | 2.64 | 6.17 | 0.71 | 3.47 | 14.73 |
Net Debt / FCF Ratio | 4.20 | 5.38 | 17.48 | 0.99 | -5.46 | 8.27 |
Asset Turnover | 0.57 | 0.55 | 0.50 | 0.63 | 0.60 | 0.36 |
Inventory Turnover | 3.13 | 3.03 | 2.59 | 3.00 | 3.34 | 2.07 |
Quick Ratio | 1.71 | 1.60 | 1.40 | 1.75 | 1.77 | 0.28 |
Current Ratio | 2.63 | 2.59 | 2.35 | 2.65 | 2.58 | 0.43 |
Return on Equity (ROE) | 5.77% | 5.58% | 2.61% | 2.47% | 17.96% | -23.77% |
Return on Assets (ROA) | 4.53% | 4.35% | 1.80% | 2.14% | -1.37% | 0.10% |
Return on Invested Capital (ROIC) | 6.11% | 5.75% | 2.50% | 3.10% | -2.07% | 0.17% |
Return on Capital Employed (ROCE) | 7.25% | 6.89% | 3.99% | 4.42% | -1.39% | 0.42% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.24% | 3.79% | 1.80% | 2.70% | 19.49% | - |
FCF Yield | 7.04% | 7.34% | 3.19% | 9.36% | - | - |
Buyback Yield / Dilution | -6.16% | -10.98% | -3.51% | -85.72% | -19.90% | - |
Total Shareholder Return | -6.16% | -10.98% | -3.51% | -85.72% | -19.90% | - |